Araştırmacı Veysel Sabri HANÇER

54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2012, cilt.120, (Özet Bildiri)

4. Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome

Yonal I., Hindilerden F., Hancer V. S., Esen B. A., Nalcaci M., Kucukkaya R. D.

52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 4 - 07 Aralık 2010, cilt.116, ss.1303-1304, (Özet Bildiri)

5. Adamts-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome

Hancer V. s., Diz-Kucukkaya R., topal-Sarikaya A.

50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2008, cilt.112, ss.642, (Özet Bildiri)

6. CTLA-4 A49G polymorphism and autoimmune blood diseases.

Akturk F., Hancer V. S., Guvenc S., Artim-esen B., Diz-Kucukkaya R.

48th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2006, cilt.108, (Özet Bildiri)

Metrikler

Araştırmacı Veysel Sabri HANÇER

Yayınlar & Eserler

1. A Novel ATP6V0A2 Mutation Causing Recessive Cutis Laxa with Unusual Manifestations of Bleeding Diathesis and Defective Wound Healing

2. Glycoprotein Ib alpha Kozak polymorphism in patients presenting with early-onset acute coronary syndrome

3. MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms.

4. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis

5. Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients

6. Glycoprotein Ib-alpha Kozak polymorphism in ischemic stroke

7. ADAMTS-13 gene expression in antiphospholipid syndrome

8. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia

9. Cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases

10. Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk?

11. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome

1. Two Pediatric Cases of Essential Thrombocytopenia Characterized By Extremely Rare Mutations (CALR and MPL W515K)

2. Two Novel Mutations ( p.I454T and p.Y472X) and a Homozygous p.A109T Mutation Associated with Factor XI Deficiency in a Turkish Family

3. Can Activation Induced Cytidine Deaminase Lead to Genetic Instability in Bcr-Abl Negative Myeloproliferative Neoplasms?

4. Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome

5. Adamts-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome

6. CTLA-4 A49G polymorphism and autoimmune blood diseases.

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)